#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    SAPHO syndrome Cholangitis sclerosing Spinal muscular atrophy Undifferentiated sarcoma Demyelination Congenital cystic kidney disease Severe myoclonic epilepsy of infancy Hyperinsulinaemic hypoglycaemia Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Lymphatic malformation Hypersensitivity pneumonitis B-cell small lymphocytic lymphoma Primitive neuroectodermal tumour Peritoneal neoplasm Osteosarcoma metastatic More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Life with Disease Kearns-Sayre syndrome – Basic Information Chronic granulomatous disease – Basic Information Pemphigus – Basic Information Leiomyosarcoma metastatic – Basic Information Loeys-Dietz syndrome – Diagnostics Cholangitis sclerosing Hyperoxaluria Leukoencephalopathy – Diagnostics Mastocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Deupirfenidone Telisotuzumab Vedotin MRNA-1345 Tenofovir Alafenamide Bi 765845 Ertapenem Sodium DISODIUM PHOSPHATE Kpl-404 Cagrilintide Vibostolimab Nalbuphine Hydrochloride Galcanezumab Ursodoxicoltaurine DICLOFENAC POTASSIUM Opevesostat Tosilate Oxacillin Hydrocortisone Ph. Eur. Timbetasin Acetate Pilocarpine Hydrochloride Losartan Potassium More therapies…

    Learn about Your Condition

    Monogenic diabetes Anogenital dysplasia SAPHO syndrome Immune-mediated myositis Major depression Vulvovaginal pruritus Infertility male CDKL5 deficiency disorder Juvenile absence epilepsy ROHHAD syndrome Hidradenitis Oesophageal carcinoma Malignant melanoma of eyelid Prinzmetal angina Breast angiosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Telitacicept for Treating Generalized Myasthenia Gravis in Patients

    Recruiting

    3 1
    Investigated Drugs:
    • Telitacicept
    Belgium Bulgaria Czechia Denmark France Italy +2

  • Study on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Evolocumab
    France Germany Italy Poland Spain

  • Study of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis

    Recruiting

    2 1
    Investigated Drugs:
    • Namodenoson
    Bulgaria Poland Romania

  • Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Filgotinib
    Belgium Croatia France Germany Greece Ireland +6

  • Study of Vedolizumab for Children with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    Belgium Bulgaria Denmark Ireland Italy The Netherlands +4

  • Study on Valsartan for Slowing Aortic Root Dilatation in Children and Young Adults with Marfan Syndrome and Related Conditions

    Recruiting

    3 1 1
    Investigated Diseases:
    • Arterial tortuosity syndrome
    • Ehlers-Danlos syndrome
    • Loeys-Dietz syndrome
    Investigated Drugs:
    • Valsartan
    Poland
Previous Page
1 … 635 636 637 638 639 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!